Therefore, these data suggest that different FGFR2 SNPs or their combination may contribute to initiation, signalling or elevated risk of breast cancer, highlighting the importance of the analysis of FGFR2 SNPs as clinical markers or predictors. This evidence concerns the gene FGFR2 and breast cancer.